This facility aims at a thorough understanding of the in vitro pharmacology of a candidate drug therapy (single drug or a drug mixture)
The in vitro and systems pharmacology facility provides the projects at the DDD platform with a thorough understanding of the in vitro efficacy and toxicity of a drug therapy (single drug or a drug combination) using relevant cellular model systems. Situated at the Clinical Pharmacology laboratory at Uppsala University Hospital the facility also offers the possibility to support drug discovery projects by testing putative novel therapies on primary human cells. In vitro toxicity of antibacterial compounds is also tested at the Clinical Pharmacology as part of the IMI ENABLE consortium.
Time- and dose-dependence of in vitro efficacy/toxicity on cells are studied using live cell imaging, in addition to biochemical end-point assays.
We also aim at elucidating mechanism of action of novel drugs, and identify biomarker signatures, by analysing transcriptomics data.
Finally the facility also offers advice on how to incorporate the data in proof of concept studies.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.